D-0326-2023 Class II Ongoing
FDA drug recall D-0326-2023 was initiated by Consolidated Chemical, Inc on January 10, 2023 and is designated Class II. Reason for recall: CGMP Deviations: initiated due to violations of CGMP manufacturing practices The recall status is ongoing. Affected quantity: 3186 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- February 22, 2023
- Initiation Date
- January 10, 2023
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3186 bottles
Product Description
Humatrix Microclysmic Gel, 8 oz per bottle, Care-Tech Laboratories, Inc., Saint Louis, Missouri 63139.
Reason for Recall
CGMP Deviations: initiated due to violations of CGMP manufacturing practices
Distribution Pattern
Nationwide in the USA
Code Information
Lot, expiry: Lot 3216, exp 04/23 and 3218, exp 10/23